Abstract
Currently, humanity is suffering from a highly contagious and infectious novel coronavirus disease. Due to the unavailability of any specifically approved therapy to eradicate this pathogenic virus, day by day, it is claiming more and more lives of humans. Observing the current scenario, human civilization seems to be in dangerous situation, and the development of a potential vaccine against this invisible enemy may take some more time. It was observed that the individual immune system plays an important role in the fight against the novel coronavirus. Additionally, the innate immune system of the host acts as the first line of defense against invading pathogenic viruses. The host innate immune cells can detect and detoxify the evading viruses. Thus, boosting the innate immune response via targeting activator or inhibitory immune check points pathways for enhancing T-cell immune response may potentially help the patients to fight against this deadly virus. The aim of this editorial is to discuss in brief about the pathogenesis of COVID-19, the role of innate immunity and autophagy during viral clearance.
Keywords: COVID-19, convalescent plasma therapy, innate immunity, novel coronavirus, SARS-CoV-2, pathogenesis of COVID.
Coronaviruses
Title:Boosting Innate Immunity During SARS-CoV-2 Clearance
Volume: 2 Issue: 8
Author(s): Abhishesh Kumar Mehata*, Deepa Dehari, Anuj Kumar Mehta and Alim Miya
Affiliation:
- Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi– 221005,India
Keywords: COVID-19, convalescent plasma therapy, innate immunity, novel coronavirus, SARS-CoV-2, pathogenesis of COVID.
Abstract: Currently, humanity is suffering from a highly contagious and infectious novel coronavirus disease. Due to the unavailability of any specifically approved therapy to eradicate this pathogenic virus, day by day, it is claiming more and more lives of humans. Observing the current scenario, human civilization seems to be in dangerous situation, and the development of a potential vaccine against this invisible enemy may take some more time. It was observed that the individual immune system plays an important role in the fight against the novel coronavirus. Additionally, the innate immune system of the host acts as the first line of defense against invading pathogenic viruses. The host innate immune cells can detect and detoxify the evading viruses. Thus, boosting the innate immune response via targeting activator or inhibitory immune check points pathways for enhancing T-cell immune response may potentially help the patients to fight against this deadly virus. The aim of this editorial is to discuss in brief about the pathogenesis of COVID-19, the role of innate immunity and autophagy during viral clearance.
Export Options
About this article
Cite this article as:
Mehata Kumar Abhishesh*, Dehari Deepa , Mehta Kumar Anuj and Miya Alim , Boosting Innate Immunity During SARS-CoV-2 Clearance, Coronaviruses 2021; 2 (8) : e260721189347 . https://dx.doi.org/10.2174/2666796701999201222113659
DOI https://dx.doi.org/10.2174/2666796701999201222113659 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Electroporation: An Effective Method For <i>In Vivo</i> Gene Delivery
Drug Delivery Letters Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
Current Medicinal Chemistry The Potential Impact of Ayurvedic Traditional <i>Bhasma</i> on SARS-CoV- 2- Induced Pathogenesis
Current Traditional Medicine The Fundamental Role of Stress Echo in Evaluating Coronary Artery Disease in Specific Patient Populations
Current Vascular Pharmacology Effects on Cytokines and Histology by Treatment with the Ace Inhibitor Captopril and the Antioxidant Retinoic Acid in the Monocrotaline Model of Experimentally Induced Lung Fibrosis
Current Pharmaceutical Design Machine Learning and Tubercular Drug Target Recognition
Current Pharmaceutical Design Synthetic Approach to Phenylalanine-Proline, and Tyrosine-Proline Hybrid Amino Acids
Current Bioactive Compounds Calcium Antagonists: A Ready Prescription for Treating Infectious Diseases?
Current Topics in Medicinal Chemistry Women’s Health and Artificial Intelligence (AI): Addressing Potential for Bias and Discrimination in AI
Current Women`s Health Reviews Classification of Small GTPases with Hybrid Protein Features and Advanced Machine Learning Techniques
Current Bioinformatics Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19
Current Pharmaceutical Design Towards Better Drug Repositioning: Targeted Immunoinflammatory Therapy for Diabetic Nephropathy
Current Medicinal Chemistry Bioactive Cyclohexenones: A Mini Review
Current Bioactive Compounds The Biology of Persistent Infection: Inflammation and Demyelination Following Murine Coronavirus Infection of the Central Nervous System
Current Immunology Reviews (Discontinued) Novel Coronavirus Disease 2019 (COVID-19) Current Update: Perspective on Epidemiology, Diagnosis, Drug Targets and Vaccines
Coronaviruses CuAAC Click Chemistry Accelerates the Discovery of Novel Chemical Scaffolds as Promising Protein Tyrosine Phosphatases Inhibitors
Current Medicinal Chemistry The Role of CXCR3 in Neurological Diseases
Current Neuropharmacology Targeting COVID-19 in Parkinson’s Patients: Drugs Repurposed
Current Medicinal Chemistry Rational Design, Synthesis and In Vitro Evaluation of Three New Alkylating Steroidal Esters
Medicinal Chemistry The Role of Antihistamine Drugs in Allergic Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents